Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Shareholders' Equity (Unaudited) (Parenthetical)

v2.4.0.8
Condensed Consolidated Statement of Shareholders' Equity (Unaudited) (Parenthetical) (Additional Paid-In Capital, USD $)
6 Months Ended
Jun. 30, 2013
Silcon
 
Issuance of Common Stock for acquisition, per share $ 6.73
Cytochroma
 
Issuance of Common Stock for acquisition, per share $ 7.16